Publication Name	World Journal of Diabetes
Manuscript ID	105228
Country	China

Received	2025-01-15 11:05
Peer-Review Started	2025-01-16 01:00
To Make the First Decision
Return for Revision	2025-03-10 02:28
Revised	2025-03-23 16:40
Second Decision	2025-06-11 06:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-06-11 08:35
Articles in Press	2025-06-11 08:35
Publication Fee Transferred	2025-03-28 07:38
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-08-01 11:12
Publish the Manuscript Online	2025-08-14 10:51

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Basic Study
Article Title	Activation of farnesoid X receptor upregulates binding immunoglobulin protein expression and alleviates diabetic nephropathy
Manuscript Source	Unsolicited Manuscript
All Author List	Jian-Ying Tang, Yuan-Jia Chong, Lu Yang, Xue Li, Ying Yang, Jun-Chen Li and Jiao Mu
ORCID	Author(s) ORCID Number Jun-Chen Li http://orcid.org/0000-0003-4557-0595 Jiao Mu http://orcid.org/0009-0002-4402-0241
Funding Agency and Grant Number	Funding Agency Grant Number Talent Launch Fund of Chongqing Medical University Affiliated University City Hospital Chongqing Medical University Affiliated University City Hospital Youth Program No. 2021ZD05
Corresponding Author	Jun-Chen Li, Department of Nephrology, University-Town Hospital of Chongqing Medical University, No. 55 Daxuecheng Middle Road, Shapingba District, Chongqing 401331, China. 8a3610@hospital.cqmu.edu.cn
Key Words	Binding immunoglobulin protein; Chromatin immunoprecipitation; Diabetic nephropathy; Endoplasmic reticulum stress; Farnesoid X receptor
Core Tip	What was known: Farnesoid X receptor (FXR) agonists alleviate proteinuria and glomerulosclerosis in diabetic nephropathy mice by inhibiting inflammation and oxidative stress. Hence, their protective effects have become a research focus in recent years. However, the specific targets and signaling pathways involved in their regulation remain unclear. This study adds: We demonstrated for the first time that using bioinformatics prediction, protein immunoprecipitation, and luciferase reporter assays that FXR directly binds to the promoter region of the binding immunoglobulin protein (BiP) gene. FXR activates the transcriptional activity of BiP, thereby explaining the molecular mechanism of FXR-regulated BiP transcription. We confirmed through in vitro experiments that FXR agonist obeticholic acid (INT-747) administration significantly promotes BiP expression in high-glucose-induced SV40 MES13 cells, while FXR inhibitors downregulated BiP expression. Potential impact: FXR has a direct regulatory effect on BiP. This study provides valuable insights regarding the prevention and treatment of diabetic nephropathy.
Publish Date	2025-08-14 10:51
Citation	<p>Tang JY, Chong YJ, Yang L, Li X, Yang Y, Li JC, Mu J. Activation of farnesoid X receptor upregulates binding immunoglobulin protein expression and alleviates diabetic nephropathy. <i>World J Diabetes</i> 2025; 16(8): 105228</p>
URL	https://www.wjgnet.com/1948-9358/full/v16/i8/105228.htm
DOI	https://dx.doi.org/10.4239/wjd.v16.i8.105228

Full Article (PDF)	WJD-16-105228-with-cover.pdf
The ARRIVE Guidelines	105228-The-ARRIVE-Guidelines.pdf
Manuscript File	105228_Auto_Edited_065612.docx
Answering Reviewers	105228-answering-reviewers.pdf
Audio Core Tip	105228-audio.mp3
Biostatistics Review Certificate	105228-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	105228-conflict-of-interest-statement.pdf
Copyright License Agreement	105228-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	105228-foundation-statement.pdf
Institutional Animal Care and Use Committee Approval Form or Document	105228-institutional-animal-care-and-use-committee-statement.pdf
Non-Native Speakers of English Editing Certificate	105228-non-native-speakers.pdf
Peer-review Report	105228-peer-reviews.pdf
Scientific Misconduct Check	105228-scientific-misconduct-check.png
Scientific Editor Work List	105228-scientific-editor-work-list.pdf
CrossCheck Report	105228-crosscheck-report.pdf